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Abstract
Background: Spatial discrimination thresholds (SDTs) assess somatosensory integration, and provide a window into better understanding the pathophysiology of
dystonia. They are abnormal in some focal dystonias, but normal in DYT1 dystonia. It is unknown whether SDTs are altered in DYT6 gene mutation carriers (C).
Methods: SDTs were assessed in 17 DYT6 C (including eight manifesting carriers), 15 DYT1 C (including seven manifesting carriers) and 34 controls, using a
standardized grating orientation task. Subjects were asked to recognize the orientation of Johnson–Van Boven–Philips (JVP) dome gratings on either index fingertip
until 40% or more answers were incorrect. SDTs between indexes were calculated and averaged, with a final SDT assigned to each subject, and tertiles for control
SDTs were constructed.
Results: SDTs of DYT6 C or DYT1 C were comparable to those of controls, and not more likely to be in the worst tertile (p50.8 for DYT6 C vs. controls and
p51.0 for DYT1 C vs. controls). This was independent of gene expression.
Discussion: DYT6 carriers do not have impaired SDTs with the JVP dome paradigm. The normal SDT pattern thus suggests shared sensory physiologic patterns
with DYT1 dystonia.
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Introduction
Dystonia is characterized by involuntary, sustained muscle contrac-
tions that result in twisting and repetitive movements and abnormal
postures.1 Both neurophysiologic and clinical observations suggest that
dystonia is associated with a disturbance of sensory integration.
Clinically, there is often improvement of dystonic postures using
sensory tricks (gestes antagonistes).2 Although basal ganglia dysfunction
likely contributes to the pathogenesis of genetic dystonia, expanded
neuronal circuits have been implicated. Positron emission tomography
(PET) studies in carriers of the DYT1 dystonia mutation suggest
overexcitability of the sensorimotor system,3 whereas reductions in
cerebello-thalamic connectivity are thought to correlate with disease
expression in both DYT1 and DYT6 gene mutation carriers.4 Several
models of sensory processing dysfunction in dystonia have been
proposed,2,5,6 and the role of somatosensory abnormalities in disease
pathogenesis warrants further study.
Mapping with somatosensory evoked potentials demonstrates
abnormal homuncular organization of finger representations in the
primary somatosensory cortex in a primate genesis model of focal
dystonia and repetitive strain injury.7 A disorganized pattern, which
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correlates with dystonia severity, is also seen in humans with brachial
dystonia.6 Although some functional neuroimaging studies have
demonstrated decreased sensorimotor activation in dystonia (due
perhaps to the heterogeneity of the cohorts of the patients examined),8
the majority of studies suggests overactivation of contralateral
sensorimotor and supplemental motor cortex. Motor tasks, such as
repetitive learning show activation in bilateral dorsal pre-motor and
inferior parietal association cortex,3,9–11 and contralateral dorsolateral
prefrontal cortex (gyrus frontalis medialis, superior frontal gyrus,
fronto-orbital cortex) as well. Functional imaging also supports cortical
sensory abnormalities in response to vibratory stimuli, albeit decreased,
as measured by PET and H2(15)O blood flow scanning where the
peaks were reduced in the primary sensorimotor area and supple-
mentary motor area in writer’s cramp.12 Although the etiology of
dystonia is often unknown, two genes for primary dystonia have
been elucidated, TOR1A (DYT1) and THAP1 (DYT6). Based on
PET and magnetic resonance imaging (MRI) abnormalities, as well
as their characteristic early age of disease onset, both disorders
have been hypothesized as neurodevelopmental circuit disorders of
cortico-striatal-pallido-thalamocortical and cerebellar-thalamo-cortical
pathways.13
Spatial discrimination thresholds (SDTs) have been proposed as a
method for understanding the role of sensory processing in different
forms of dystonia through assessing the integrity of sensory integration.
The SDT describes the shortest distance interval at which two stimuli
applied to the same part of the body can be recognized as spatially
separated and can be readily tested at the bedside.14 SDTs have been
found to be normal in patients with DYT1 dystonia, but impaired in
subjects with focal dystonias, notably, writer’s cramp, blepharospasm,
and cervical dystonia.15 Although SDT testing is less sensitive in
patients with adult-onset focal dystonias than another task of sensory
discrimination, the temporal discrimination threshold (TDT),16 SDT is
highly portable and readily assessed.
SDT has not been evaluated in DYT6 gene (THAP1) mutation
carriers. As DYT6 may present with focal or segmental dystonia,
including writer’s cramp and craniocervical dystonia,17–21 this study
was performed to establish whether SDTs are abnormal in DYT6
mutation carriers, and may be an endophenotype of DYT6 dystonia.
Further, penetrance of the DYT6 and DYT1 genes is reduced, and
symptoms of dystonia are present in approximately 60% of cases22
with DYT6 mutations and 30–40% of those with DYT1 mutations.23
As both DYT1 and DYT6 gene carriers who do not express symptoms
may have abnormal brain circuitry, a function endophenotype of
carrying the mutated THAP gene has been proposed.13 In order to
determine whether SDTs could detect a sensory endophenotype of




Subjects who participated in ongoing genetic studies of dystonia and
movement disorders were recruited for SDT assessment and gave
informed consent. This study was approved by the Internal Review
Board at Beth Israel Medical Center. For dystonia family members,
mutations in THAP1 and DYT1 were assessed as previously
reported.17,24 Controls were recruited from married-in or non-
mutation carrying family members of probands and laboratory
members. We evaluated DYT6 mutation carriers (C), both with
dystonia (manifesting carriers, MC) and without (non-manifesting
carriers, NMC), and compared these with unaffected controls.
Sensory testing
SDTs were tested using a standardized grating orientation task,
which employs plastic Johnson–Van Boven–Philips (JVP) domes
(Stoelting Co, IL, http://www.stoeltingco.com/stoelting/3129/
1465/1480/Physio/JVP-Domes), as has been previously reported.15,25
The subjects were seated facing the examiner and blindfolded, with the
right index finger resting extended against a table and the distal finger
fat pad facing up. Each dome was applied on the fingertips a total of
20 times for about 1–2 seconds each time, starting with the largest
width grating (4.5 mm for subjects aged 46 or more and 2.5 mm for
subjects aged less than 46 years) and proceeding through gradually
narrower ones (the dome with the smallest width grating was
0.75 mm). The purpose of using the widest grating for the older
subgroup of subjects was to account for the expected age-related
decline in sensory discrimination.25,26 Domes were applied randomly
with the gratings aligned either parallel (‘‘down’’) or perpendicular
(‘‘across’’) to the axis of the finger, and with enough pressure to indent
the skin by 1 mm. Prior to asking subjects to recognize the grating
orientation in a blinded fashion, subjects were trained on the different
orientations for each different grating size. The process continued until
eight (40%) or more answers for a given grating width were incorrect.
Sensory testing was then repeated on the contralateral index finger
following the same paradigm. Subjects who attained 40% or more
incorrect responses for the largest (4.5 mm or 2.5 mm, depending on
the subject’s age at the time of testing) groove widths were assigned the
threshold of the largest width tested within their age group. The SDT
for each hand was calculated by linear interpolation of the 75% level of
accuracy and the final SDT was calculated as the mean of both index
fingers.
Data analysis
SDTs from controls were divided by age into two groups (46 years
or older and less than 46 years). Tertiles for each group were
constructed, with the third (or highest) tertile containing SDTs from
those individuals with the poorest performance. Non-control subjects
were then categorized based on the control tertiles. Individuals scoring
in the first two tertiles were considered to have normal SDTs, and
those within the third tertile were considered abnormal. The distribu-
tion of abnormal SDTs was first compared between all DYT6 mutation
carriers and controls (STATA10, StataCorp LP, TX). To determine
whether the presence of abnormal SDTs was a disease effect rather
than a gene effect, we then divided the gene mutation carrier groups
into MC and NMC, and compared each of these subgroups with
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controls using Fisher’s exact test. These analyses were repeated
comparing DYT1 groups with controls.
As botulinum toxin type A (BntxA) has been shown to transiently
improve the SDT in patients with cervical dystonia, presumably by
modulating afferent cortical inputs from muscle spindles,26 we
performed post hoc analyses on the subgroups of MC who had not
received BntxA injections in the previous 3 months. We also compared
SDT means stratified by age (subjects 45 years and younger or subjects
older than 45 years) with controls.
Results
Seventy-five subjects were studied: 20 DYT6 C (including 10 DYT6
MC), 19 DYT1 C (of which 10 were DYT1 MC), and 36 healthy
controls. To be eligible for the domes paradigm, subjects could not
have evidence of central or peripheral neurologic abnormalities
accounting for deficiencies in distal hand sensation (mainly, but not
limited to, a known history or symptoms suggestive of carpal tunnel
syndrome or sensory polyneuropathy), or other potential conditions
that may falsely elevate their SDTs, such as the presence of heavy
palmar callouses or a history of prolonged exposure to vibrating tools.
After applying these exclusion criteria, a total of 66 subjects (eight
DYT6 MC, nine DYT6 NMC, seven DYT1 MC, eight DYT1 NMC
and 34 controls) completed the study. General characteristics of all
groups are summarized in Table 1. Clinical characteristics of DYT1
MC and DYT6 MC are described in Table 2.
SDTs were not more likely to be in the worst tertile in DYT6 C
compared with controls (p50.8), and this was independent of gene
expression. That is, there was no difference between SDTs of the
subgroups of DYT6 C (DYT6 MC and DYT6 NMC) when compared
with controls (p50.2 and 1.0, respectively). Tertile distribution of
SDTs for controls and DYT6 C, MC and NMC is summarized in
Table 3. As expected, DYT1 C (p51.0), MC (p51.0) and NMC
(p51.0) were not more likely to have abnormal discrimination as
defined as in the upper tertile compared with controls. Sensitivity
subanalysis of the smaller group of DYT6 C who did not receive BntxA
injections 3 months prior to sensory testing also did not show a
difference from controls (p50.8).
Similar to the tertile approach, examination of raw data comparing
age-stratified SDT means with those of controls showed no significant
differences between the groups. DYT6 C ages 45 years and younger
were not different from controls (p50.3); DYT6 MC, NMC and
control values were also not different (p50.7). DYT1 C younger than
46 years were not different from controls (p50.9), nor was the
comparison of DYT1 MC, NMC and controls (p50.7). For individuals
aged 46 years and older, comparing DYT6 C vs. controls and MC,
NMC, and controls, (p50.9 and 0.5, respectively), and DYT1 C vs.
controls (p50.8) was also not significant.
Discussion
Our results suggest that DYT6 mutation carriers, both manifesting
and non-manifesting, do not have impaired SDTs. In agreement with
a prior report,15 we further demonstrate that DYT1 MC also do not
have abnormal SDTs. As similar results were noted in DYT6 and
DYT1 mutation carriers, we postulate that the integrity of higher
sensory circuitry assessed in the SDT paradigm is not compromised, or
is compensated for, in both genetic forms of dystonia.
Neural circuit similarities have been noted in functional and MRI of
both DYT1 and DYT6 dystonia carriers manifesting with dystonia.
Fluorodeoxyglucose PET studies demonstrate that both DYT1 C and
DYT6 C show relative metabolic increases in the pre-supplementary
motor area and parietal association regions.27,28 Further, both DYT1 C
and DYT6 C scanned with [11C]-raclopride PET were found to have
Table 1. Subject Demographics










DYT1 C 15 43.2 (10/5) (14/1)
DYT1 MC 7 39.2 (4/3) (6/1) c.904_906delGAG 8.5 23.2
DYT1 NMC 8 48.6 (6/2) (8/0) c.904_906delGAG
DYT6 C 17 41.8 (11/6) (13/4)




DYT6 NMC 9 47.4 (6/3) (7/2) indel (n57)
c.65TRC (n52)
Controls 34 33.1 (16/18) (34/0)
Abbreviations: C, carriers; MC, manifesting carriers; NMC, non-manifesting carriers.
1Amish-Mennonite Founder Insertion deletion (indel) mutation c.134_135insGGGTT; 137_139delAAC
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Table 2. Clinical Characteristics of DYT1 and DYT6 Manifesting Carriers










1 43.2 8.0 35.2 TAMRG * Yes
2 39.2 10.0 29.2 AMRG * No
3 39.6 9.0 30.6 AMKRG * No
4 23.1 7.0 16.1 AMG * Yes
5 23.3 6.0 17.3 UFLNAMKRG * Yes
6 19.0 13.0 6.0 ARG * Yes
7 53.5 12.0 41.5 A * No
DYT6
8 19.0 8.0 11.0 TNAMR indel3 Yes
9 19.4 16.0 3.4 L indel No
10 50.5 21.0 29.5 FJTNA indel No
11 24.0 3.0 21.0 LNAMRG indel No
12 17.7 2.0 15.7 FJTAMKRG indel No
13 45.7 12.0 33.7 FJTNAMKRG c.65TRC No
14 41.7 29.0 12.7 NA c.61T.A No
15 18.8 11.0 7.8 FTAMKR indel No
Abbreviations: A, right arm; BntxA, botulinum toxin type A; F, lower face; G, left leg; J, jaw; K, trunk; L, larynx; M, left arm; N, neck; R, right leg; T, tongue; U, upper face.
1All were right-hand dominant except subjects 7, 11, and 15.
2Sites affected at time of Johnson–Van Boven–Philips testing.
3Amish-Mennonite Founder Insertion deletion (indel) mutation c.134_135insGGGTT; 137_139delAAC
*All DYT1 mutation carriers harbored c.904_906delGAG.





























1st 1.09–1.64 1.95–2.44 12 (35.3) 7 (46.7) 2 (28.6) 5 (62.5) 8 (47.1) 4 (50) 4 (44.4)
2nd 1.73–2.33 3.39–3.48 9 (26.5) 3 (20) 3 (42.9) 0 (0) 4 (23.5) 3 (37.5) 1 (11.1)
3rd 2.38–2.87 3.82–3.84 13 (38.2) 5 (33.3) 2 (28.6) 3 (37.5) 5 (29.4) 1 (12.5) 4 (44.4)
Totals 34 (100) 15 (100) 7 (100) 8 (100) 17 (100) 8 (100) 9 (100)
Abbreviations: MC, manifesting carriers; NMC, non-manifesting carriers.
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reductions in putamen and caudate D2 receptor availability, and
recent work with diffusion tensor imaging MRI also suggests that both
DYT1 C and DYT6 C share two discrete areas of reduced pathway
connectivity in the cerebello-thalamo-cortical projection system.13
However, there are also differences noted on functional imaging:
raclopride PET demonstrates significantly more pronounced reduc-
tions in DYT6 than in DYT1 in striatal D2 availability.13 The absence
of an abnormality suggests that the SDT is not mediated through the
cortico-striatal-pallido-thalamocortical and cerebellar-thalamo-cortical
circuits abnormal in DYT1 and DYT6 dystonia, or that there is
compensation in the circuitry, which facilitates normal sensory
discrimination with this task.
Although studies in non-DYT1 families suggest that SDT may
identify an endophenotype of gene carriers in unaffected family
members of dystonia subjects,25 we did not detect SDT abnormalities
in either the DYT6 NMC or the DYT1 NMC. This differs from
functional imaging studies, which suggest that DYT1 NMC and DYT6
NMC have striatal metabolic abnormalities accompanied by changes
in D2 receptor availability.13
There are several potential limitations to this study including age
differences between the groups, treatment with botulinum toxin A in
some subjects, paradigm sensitivity, and a relatively small sample size.
The dystonia groups differed in age, with the DYT6 MC group
younger than the other groups. We therefore corrected for the age-
related decline in sensory discrimination by using domes with a larger
width grating, and, as expected, this caused a pronounced increase in
the calculated threshold of subjects with impaired sensory discrimina-
tion. Nonetheless, despite the correction, we were unable to find a
significant difference in SDTs in DYT1 and DYT6 subjects compared
with controls.
Additionally, one (12.5%) of our DYT6 MC and four (57%) of the
DYT1 MC had received BntxA within the last 3 months prior to
sensory testing. The role of BntxA in affecting sensory discrimination is
still not well understood. However, it has been suggested that BntxA
may modulate afferent cortical inputs from muscle spindles and cause
a sensory cortical reorganization in adult-onset primary torsion
dystonia patients receiving this treatment.26 Therefore we cannot be
certain that the absence of an abnormality in SDT could be a
medication-related effect. Although in their original study of DYT1
subjects, the 2 out of the 13 DYT1 MC who were on BntxA therapy
did not receive injections in at least 3 months prior to testing,15 which
argues in favor of normal SDTs in DYT1 regardless of treatment, the
small sample size in their and our study precludes proper assessment of
a BntxA effect.
Although we did not detect an abnormality with the JVP domes, we
cannot exclude that there is a sensory endophenotype associated with a
DYT6 mutation that is not captured with this paradigm. We may not
have had sufficient power to detect smaller changes in sensory
discrimination abnormalities. Our sample size was limited by the
availability of subjects with genetic forms of dystonia; therefore, there
was only adequate power to detect differences greater than 0.35
between proportions. The rarity of DYT6 renders obtaining greater
sample sizes impractical.
The limitations may extend beyond sample size; SDT testing may
not be a sufficiently sensitive test. Potential reasons include the already
mentioned age-related loss of sensory discrimination and operator-
dependent variations such as inconsistent pressure applied to the
fingertips, a variable and inconsistent time during which the dome is
applied, or inadvertent feedback to the study subject regarding the
orientation of the domes. Sensory disturbances may be mild enough in
DYT1 (and perhaps also in DYT6) that SDT testing simply fails to
detect them. Employment of more sensitive techniques to measure
sensory integration in DYT6 carriers may prove useful. TDT is defined
as the shortest time interval at which two stimuli are discerned as
separate. Studies indicate that such thresholds are higher in patients
with DYT1 dystonia,29 and cervical and focal-hand dystonia30 than in
healthy controls. Abnormalities in the TDT may represent a reliable
endophenotype in those predisposed family members who have not
manifested with adult-onset focal dystonia.30,31 As TDT testing is more
sensitive than SDT in adult-onset focal dystonia,16 it may demonstrate
changes in sensory integration abnormalities in DYT6 dystonia, and
should be tested in this population.
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